跳至主要内容
临床试验/2022-502512-36-00
2022-502512-36-00招募中2 期

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease

Aarhus University2 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2023年3月6日最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
39
试验地点
2
主要终点
MR xenon ventilation and dissolved parameters

研究概览

简要总结

This project aims to investigate the potential of non-invasive imaging to identify and monitor the earliest signs and physiological effects of pulmonary fibrosis and resulting cardiac dysfunction in patients with fibrosing interstitial lung disease. Second, to evaluate baseline risk factors the progression and therapeutic responses to anti-fibrotic drugs.

入排标准

年龄范围
18 years 至 65+ years(65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • Patients diagnosed with IPF or fibrotic ILD who fulfills PPF criteria, and are prescribed antifibrotic treatment.
  • Cognitively able to understand and participate in the study
  • Pre-menopausal women must be confirmed non-pregnant by an onsite test.

排除标准

  • Contraindications for MRI (Pacemaker, neurostimulator or cochlear implant; Metal foreign bodies such as fragments and irremovable piercings; Unsafe medical implants (safety of heart valves, hips and the like must be confirmed); Intrathoracic clips or coils; Cardiac pacemakers; Claustrophobia; Largest circumference including arms > 160 cm)
  • Contraindications to gadolinium contrast (eGFR < 30 mL/min/1.73m2; Previous adverse reactions to gadolinium)
  • Overlapping emphysematic disease where the emphysema-component outweighs the fibrosis
  • Unable to perform breath-hold of minimum 20 seconds.
  • Allergy to Xenon
  • Breast feeding
  • Evidence of ongoing respiratory infections at time of MR examinations

结局指标

主要结局

MR xenon ventilation and dissolved parameters

MR xenon ventilation and dissolved parameters

Worsening of pulmonary function test parameters

Worsening of pulmonary function test parameters

Worsening of HRCT parameters

Worsening of HRCT parameters

Worsening in patient reported symptoms

Worsening in patient reported symptoms

次要结局

  • Regionally decreased perfusion
  • Evidence of myocardial stran and fibrosis
  • Late contrast enhancement

研究者

申办方类型
Educational Institution
责任方
Principal Investigator
主要研究者

Mattias Kristensen

Scientific

Aarhus University

研究点 (2)

Loading locations...

相似试验